Effect of semaglutide on liver enzymes and markers of inflammation in subjects with type 2 diabetes and/or obesity.
Quick Facts
What This Study Found
Key Numbers
How They Did This
Why This Research Matters
What This Study Doesn't Tell Us
Trust & Context
- Original Title:
- Effect of semaglutide on liver enzymes and markers of inflammation in subjects with type 2 diabetes and/or obesity.
- Published In:
- Alimentary pharmacology & therapeutics, 50(2), 193-203 (2019)
- Authors:
- Newsome, Philip, Francque, Sven, Harrison, Stephen, Ratziu, Vlad, Van Gaal, Luc, Calanna, Salvatore, Hansen, Morten, Linder, Martin, Sanyal, Arun
- Database ID:
- RPEP-04392
Evidence Hierarchy
Read More on RethinkPeptides
Related articles coming soon.
Cite This Study
https://rethinkpeptides.com/research/RPEP-04392APA
Newsome, Philip; Francque, Sven; Harrison, Stephen; Ratziu, Vlad; Van Gaal, Luc; Calanna, Salvatore; Hansen, Morten; Linder, Martin; Sanyal, Arun. (2019). Effect of semaglutide on liver enzymes and markers of inflammation in subjects with type 2 diabetes and/or obesity.. Alimentary pharmacology & therapeutics, 50(2), 193-203. https://doi.org/10.1111/apt.15316
MLA
Newsome, Philip, et al. "Effect of semaglutide on liver enzymes and markers of inflammation in subjects with type 2 diabetes and/or obesity.." Alimentary pharmacology & therapeutics, 2019. https://doi.org/10.1111/apt.15316
RethinkPeptides
RethinkPeptides Research Database. "Effect of semaglutide on liver enzymes and markers of inflam..." RPEP-04392. Retrieved from https://rethinkpeptides.com/research/newsome-2019-effect-of-semaglutide-on
Access the Original Study
Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.
This study breakdown was produced by the RethinkPeptides research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.